On June 2, the Computerworld Honors Program selected IBM as one of its 2009 laureates for its contribution to EuResist, a free online computer program designed to assist doctors in determining optimal drug combination therapies for HIV patients.

EuResist recommends a combination of drugs to help prevent the development of drug resistance, which is the ability of the virus to mutate or change so that the drug is no longer effective. This is not only dangerous for the infected individual but also provides real challenges to drug developers, who must…